Author: ten Oever, Jaap; Kox, Matthijs; van de Veerdonk, Frank L; Mothapo, Khutso M; Slavcovici, Adriana; Jansen, Tim L; Tweehuysen, Lieke; Giamarellos-Bourboulis, Evangelos J; Schneeberger, Peter M; Wever, Peter C; Stoffels, Monique; Simon, Anna; van der Meer, Jos WM; Johnson, Melissa D; Kullberg, Bart-Jan; Pickkers, Peter; Pachot, Alexandre; Joosten, Leo AB; Netea, Mihai G
Title: The discriminative capacity of soluble Toll-like receptor (sTLR)2 and sTLR4 in inflammatory diseases Document date: 2014_11_19
ID: 0zkeoa1z_4
Snippet: The aim of the present study was to gain more insight into the release of sTLR2 and sTLR4 in-vitro and to investigate the kinetics of monocytic TLR2 and TLR4 expression and plasma levels of their soluble counterparts during experimental endotoxemia (intravenous LPS administration in healthy volunteers). Furthermore, we hypothesized that sTLR2 and sTLR4, being soluble forms of receptors that play pivotal roles in pathogen recognition by cells of t.....
Document: The aim of the present study was to gain more insight into the release of sTLR2 and sTLR4 in-vitro and to investigate the kinetics of monocytic TLR2 and TLR4 expression and plasma levels of their soluble counterparts during experimental endotoxemia (intravenous LPS administration in healthy volunteers). Furthermore, we hypothesized that sTLR2 and sTLR4, being soluble forms of receptors that play pivotal roles in pathogen recognition by cells of the innate immune system, are differentially released during various inflammatory diseases, with higher levels in inflammatory conditions of infectious origin. As such, we evaluated the ability of sTLR2 and sTLR4 levels to discriminate between infectious and noninfectious inflammatory pathologies.
Search related documents:
Co phrase search for related documents- high level and immune system: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- high level and infectious origin: 1
- high level and inflammatory condition: 1, 2, 3
- high level and inflammatory disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- high level and inflammatory pathology: 1
- high level and innate immune system: 1, 2, 3, 4, 5, 6
- high level and innate immune system cell: 1
- high level and insight gain: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- immune system and infectious origin: 1
- immune system and inflammatory condition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- immune system and inflammatory disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- immune system and inflammatory disease release: 1, 2
- immune system and inflammatory pathology: 1, 2, 3, 4, 5
- immune system and innate immune system: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- immune system and innate immune system cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- immune system and insight gain: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- immune system and LPS administration: 1, 2, 3, 4, 5
- infectious origin and innate immune system: 1
- infectious origin and insight gain: 1
Co phrase search for related documents, hyperlinks ordered by date